testosterone enanthate has been researched along with Hepatocellular Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, H; Endo, S; Fukuzawa, J; Hanawa, N; Hano, H; Ika, M; Itoh, S; Izu, A; Kato, K; Matsuo, R; Sato, Y; Shimizu, S; Sugitani, M; Tsubota, A; Yonezawa, T | 1 |
| Berenguer, J; Carrasco, D; Cruz, JM; Moll, JL; Muñoz, C; Pallardó, L; Prieto, M | 1 |
1 review(s) available for testosterone enanthate and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Multiple hepatic adenomas after long-term therapy with testosterone enanthate. Review of the literature.
Topics: Adult; Anabolic Agents; Carcinoma, Hepatocellular; Humans; Kidney Transplantation; Liver Neoplasms; Male; Neoplasms, Multiple Primary; Nephritis, Hereditary; Structure-Activity Relationship; Testosterone; Time Factors | 1985 |
1 other study(ies) available for testosterone enanthate and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Hepatocellular adenoma in a woman who was undergoing testosterone treatment for gender identity disorder.
Topics: Adult; Androgens; Carcinoma, Hepatocellular; Female; Gender Identity; Humans; Liver Neoplasms; Neoplasms, Multiple Primary; Testosterone | 2018 |